Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma

BACKGROUND: We assessed outcome of patients with moderate and severe COVID-19 following treatment with convalescent plasma (CP) and the association with IgG levels in transfused CP. METHODS: A prospective cohort study. Primary outcome was improvement at day 14 defined as alive, not on mechanical ven...

Descripción completa

Detalles Bibliográficos
Autores principales: Maor, Yasmin, Cohen, Daniel, Paran, Nir, Israely, Tomer, Ezra, Vered, Axelrod, Ofra, Shinar, Eilat, Izak, Marina, Rahav, Galia, Rahimi-Levene, Naomi, Bazofin, Baruch M, Gelman, Ram, Dicker, Dror, Brosh-Nissimov, Tal, Megged, Orli, Dahan, David, Benov, Avi, Paz, Alona, Edward, Kaykov, Moran, Amit, Rogowski, Ori, Sorkine, Patrick, Mayo, Ami, Zimhony, Oren, Chen, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480446/
https://www.ncbi.nlm.nih.gov/pubmed/32923991
http://dx.doi.org/10.1016/j.eclinm.2020.100525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480446/
https://www.ncbi.nlm.nih.gov/pubmed/32923991
http://dx.doi.org/10.1016/j.eclinm.2020.100525

Ejemplares similares